Coxem carries a market capitalization of 37.70B, placing it among publicly traded companies globally. Its enterprise value stands at 81.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 37.70B |
| Enterprise Value | 81.71B |
Coxem trades at a trailing price-to-earnings ratio of 1,638.99. The price-to-sales ratio is 6.85, and the price-to-book ratio stands at 8.55.
| PE Ratio | 1,638.99 |
| PS Ratio | 6.85 |
| PB Ratio | 8.55 |
| P/TBV Ratio | 5.47 |
| P/FCF Ratio | -53.84 |
| P/OCF Ratio | -43.11 |
| EV / Sales | 6.40 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 68.42 |
Coxem maintains a current ratio of 4.15, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.34, indicating elevated leverage, while an interest coverage ratio of -25.68 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.15 |
| Quick Ratio | 2.09 |
| Debt / Equity | 16.34 |
| Debt / EBITDA | -1.18 |
| Interest Coverage | -25.68 |
| Return on Equity (ROE) | -11.80 |
| Return on Assets (ROA) | -5.14 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.20 |
| Income Tax | -485.55M |
| Effective Tax Rate | N/A |
Coxem's stock has declined approximately -12.5% over the past 52 weeks. The 50-day moving average sits at 10,819.40, while the 200-day moving average is 9,375.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | -12.5% |
| 50-Day Moving Average | 10,819.40 |
| 200-Day Moving Average | 9,375.85 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Coxem generated 12.77B in revenue and converted that into -1.28B in net income, yielding earnings per share of -278.53. EBITDA reached -2.28B, while operating income came in at -2.28B.
| Revenue | 12.77B |
| Gross Profit | 5.04B |
| Operating Income | -2.28B |
| Pretax Income | -2.00B |
| Net Income | -1.28B |
| EBITDA | -2.28B |
| EBIT | -2.28B |
| Earnings Per Share (EPS) | -278.53 |
Coxem holds 8.09B in cash and equivalents against 2.69B in total debt, resulting in a net debt position of 1.09B. Total book value stands at 10.22B, with working capital of 12.18B providing operational flexibility.
| Cash & Cash Equivalents | 8.09B |
| Total Debt | 2.69B |
| Net Debt | 1.09B |
| Equity (Book Value) | 10.22B |
| Book Value Per Share | 1,874.22 |
| Working Capital | 12.18B |
Coxem produced -2.03B in operating cash flow over the past twelve months. After subtracting -404.39M in capital expenditures, free cash flow totaled -2.43B - equivalent to -446.02 per share.
| Operating Cash Flow | -2.03B |
| Capital Expenditures | -404.39M |
| Free Cash Flow | -2.43B |
| FCF Per Share | -446.02 |
Coxem operates with a gross margin of 39.50, reflecting its pricing power and cost economics. The operating margin of -17.88 and net profit margin of -10.03 provide insight into operational efficiency.
| Gross Margin | 39.50 |
| Operating Margin | -17.88 |
| Pretax Margin | -15.70 |
| Profit Margin | -10.03 |
| EBITDA Margin | -17.88 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.73 |
| FCF Yield | -1.86 |
Coxem posts an Altman Z-Score of 11.79, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.79 |